Shanghai Pharmaceuticals Holding Co Financial Overview
Shanghai Pharmaceuticals Holding Co's market cap is currently $8.55B. The company's EPS TTM is $0.026984940000000002; its P/E ratio is 7.26; and it has a dividend yield of 3.35%. Shanghai Pharmaceuticals Holding Co is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
